Literature DB >> 2492775

Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus.

C Krishnamurti1, L M Wahl, B M Alving.   

Abstract

Human monocytes, in an essentially serum-free culture medium, were infected with dengue 2 virus in the presence of sub-neutralizing concentrations of antibody. Changes in procoagulant activity (PCA), in the plasminogen activator urokinase (UK), and the plasminogen activator inhibitor-2 (PAI-2) were quantitated. One day after exposure to dengue virus, the cell-associated PAI-2 activity in the infected monocytes was 562 +/- 9 mU/10(6) cells (mean +/- SE) compared to 206 +/- 56 mU/10(6) cells for uninfected monocytes. Supernatants of the infected cells also showed greater than 2-fold increase in PAI-2 activity. This increase in cell-associated and supernatant PAI-2 activity was maintained during 4 days of culture. UK activity was not detected in control and infected cells nor in their supernatants. PCA activity was the same in control and dengue virus infected monocytes when measured during 4 days of culture. These data suggest that dengue infected monocytes may affect fibrinolysis at a localized level through increased production of PAI-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492775     DOI: 10.4269/ajtmh.1989.40.102

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter.

Authors:  E Cousin; R L Medcalf; G E Bergonzelli; E K Kruithof
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

2.  Fibrin formation and lysis studies in dengue virus infection.

Authors:  Rita Marchi; Chandrasekaran Nagaswami; John W Weisel
Journal:  Blood Coagul Fibrinolysis       Date:  2009-10       Impact factor: 1.276

3.  The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming.

Authors:  T M Antalis; M La Linn; K Donnan; L Mateo; J Gardner; J L Dickinson; K Buttigieg; A Suhrbier
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

Review 4.  Tissue factor in COVID-19-associated coagulopathy.

Authors:  Saravanan Subramaniam; Hema Kothari; Markus Bosmann
Journal:  Thromb Res       Date:  2022-10-01       Impact factor: 10.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.